UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000017299
Receipt No. R000020045
Official scientific title of the study Detection of Urologic Cancers and Chronic Kidney Disease in Patients with COPD
Date of disclosure of the study information 2015/05/01
Last modified on 2018/05/02 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Detection of Urologic Cancers and Chronic Kidney Disease in Patients with COPD
Title of the study (Brief title) DUCK Study
Region
Japan

Condition
Condition COPD
Classification by specialty
Pneumology Nephrology Urology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate prevalence of coexisting urologic cancers and CKD in COPD
Basic objectives2 Others
Basic objectives -Others Prevalence
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Prevalence of urologic cancers and CKD
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Other
Interventions/Control_1 Performe urine test and estimate eGFR
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with COPD confirmed by spirometry who have a history of smoking
Key exclusion criteria Patients already diagnosed urologic cancers. Patients with acute renal failure.
Target sample size 400

Research contact person
Name of lead principal investigator Seiichi Kobayashi
Organization Japanese Red Cross Ishinomaki Hospital
Division name Department of Respiratory Medicine
Address 71 Nishimichishita, Hebita, Ishinomaki, Japan
TEL 0225-21-7220
Email skoba-thk@umin.ac.jp

Public contact
Name of contact person Seiichi Kobayashi
Organization Japanese Red Cross Ishinomaki Hospital
Division name Department of Respiratory Medicine
Address 71 Nishimichishita, Hebita, Ishinomaki, Japan
TEL 0225-21-7220
Homepage URL
Email skoba-thk@umin.ac.jp

Sponsor
Institute Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 石巻赤十字病院(宮城県)

Other administrative information
Date of disclosure of the study information
2015 Year 05 Month 01 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2015 Year 04 Month 21 Day
Anticipated trial start date
2015 Year 05 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Prospective study

Management information
Registered date
2015 Year 04 Month 27 Day
Last modified on
2018 Year 05 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020045